PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment

Severe asthma accounts for almost half the cost associated with asthma. Severe asthma is driven by heterogeneous molecular mechanisms. Conventional clinical trial design often lacks the power and efficiency to target subgroups with specific pathobiological mechanisms. Furthermore, the validation and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2021-05, Vol.147 (5), p.1594-1601
Hauptverfasser: Israel, Elliot, Denlinger, Loren C., Bacharier, Leonard B., LaVange, Lisa M., Moore, Wendy C., Peters, Michael C., Georas, Steve N., Wright, Rosalind J., Mauger, David T., Noel, Patricia, Akuthota, Praveen, Bach, Julia, Bleecker, Eugene R., Cardet, Juan Carlos, Carr, Tara F., Castro, Mario, Cinelli, Angeles, Comhair, Suzy A.A., Covar, Ronina A., Alexander, Laura Crotty, DiMango, Emily A., Erzurum, Serpil C., Fahy, John V., Fajt, Merritt L., Gaston, Benjamin M., Hoffman, Eric A., Holguin, Fernando, Jackson, Daniel J., Jain, Sonia, Jarjour, Nizar N., Ji, Yuan, Kenyon, Nicholas J., Kosorok, Michael R., Kraft, Monica, Krishnan, Jerry A., Kumar, Rajesh, Liu, Andrew H., Liu, Mark C., Ly, Ngoc P., Marquis, M. Alison, Martinez, Fernando D., Moy, James N., O’Neal, Wanda K., Ortega, Victor E., Peden, David B., Phipatanakul, Wanda, Ross, Kristie, Smith, Lewis J., Szefler, Stanley J., Teague, W. Gerald, Tulchinsky, Abigail F., Vijayanand, Pandurangan, Wechsler, Michael E., Wenzel, Sally E., White, Steven R., Zeki, Amir A., Ivanova, Anastasia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!